AI has arrived - PharmaTimes Magazine October 2018

Artificial intelligence is poised to change the pharmaceutical and healthcare industries as it looks to streamline, speed-up and improve overall efficiency. It might still be early days but it's a bandwagon that organisations are quickly jumping on board. According to a CB Insights report, about 86% of healthcare organisations, life science companies and med tech firms were using artificial intelligence technology in 2016. Big pharma names announcing deals and applications include Bayer, J&J, Merck, Sanofi, Genentech and Pfizer. Meanwhile, more than 50% of healthcare industry executives anticipate broad-scale adoption of the technology by 2025, a TechEmergence study recently revealed, with nearly half of the respondents noting that chronic conditions will be the initial target.